C-ABL-IN-2 is a highly effective inhibitor of the c-Abl protein, which plays a significant role in the development of several diseases, including cancer. This compound exhibits promise for investigating neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and Parkinsons disease (PD), as well as cancer. (Source: WO2020260871A1, compound 25) [1].
Molecular Weight:
344.41
CAS Number:
[2574593-54-5]
Formula:
C21H20N4O
Target:
Others|||Bcr-Abl
T61128
* VAT and and shipping costs not included. Errors and price changes excepted
